Article
Andrographolide Causes p53-independent HCC Cell Death through p62 Accumulation and Impaired DNA Damage Repair
2023-03-10
Abstract excerpt
Hepatocellular carcinoma (HCC) is a deadly cancer, with the dominant driver mutations such as p53 yet undruggable. There is urgent demand to search for novel agents and therapeutic targets for HCC treatment. Andrographolide (Andro, a clinical-available anti-inflammation phytochemical agent) could inhibit different types of cancer including HCC, but the molecular mechanisms involved are yet unclear. The present stu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d7cdd2dd-a05e-5eb9-9ff2-9e6df0605aff
- DOI
- 10.22541/au.167844940.05342281/v1
